Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1031 | Male Reproduction | ICEECE2012

Decreased osteoprotegerin levels during testosterone therapy in ageing men were associated with changed distribution of regional fat

Glintborg D. , Frederiksen L. , Hougaard D. , Brixen K. , Rasmussen L. , Andersen M.

Objective: The cardiovascular effects of testosterone treatment are debated. Osteoprotegerin (OPG) is an independent marker of cardiovascular risk. We investigated the effect of testosterone therapy on OPG levels in ageing men with low normal bioavailable testosterone levels.Design: A randomized, double-blinded, placebo-controlled study of six months testosterone therapy (gel) in 38 men aged 60–78 years with bioavailable testosterone <7.3 nmol/l...